Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 661 across all filing types
Latest filing 2025-08-21 Governance Information
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
信息披露暂缓与豁免事务管理制度
Governance Information Classification · 95% confidence The document is a detailed internal policy and procedural manual titled 'Information Disclosure Delay and Exemption Management System' for Shenzhen Huitai Medical Devices Co., Ltd. It outlines rules, responsibilities, and forms related to delaying or exempting disclosure of certain information, including commercial secrets and national secrets, in compliance with securities laws and stock exchange regulations. It includes internal forms and confidentiality commitments. The document is not a financial report, earnings release, or announcement of voting results. It is not a regulatory filing in the sense of a compliance or certification document but rather a governance and compliance policy document related to disclosure practices. Therefore, it best fits the category of Governance Information (CGR), which covers reports detailing internal rules and governance practices. The document length is 4130 characters, which is relatively short but contains substantive governance content rather than a mere announcement or certification. Hence, the classification is CGR with high confidence.
2025-08-21 Chinese
2025年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "深圳惠泰医疗器械股份有限公司2025 年半年度报告" which translates to "Shenzhen Huitai Medical Device Co., Ltd. 2025 Semi-Annual Report." It explicitly states the report period as January 1, 2025 to June 30, 2025, indicating it covers a half-year period. The content includes detailed financial data, management discussion and analysis, company business overview, risk factors, and other comprehensive information typical of an interim or quarterly report. The document length is substantial (15,000 characters), and it contains actual financial statements and substantive analysis, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-08-21 Chinese
2025年半年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the use and management of funds raised by Shenzhen Huitai Medical Device Co., Ltd. It includes specifics on the amount of funds raised, their allocation, usage, management policies, and investment projects. The report references regulatory approvals and compliance with securities laws, and it provides detailed financial figures related to fundraising and fund usage for the half-year period ending June 30, 2025. The document is not a general annual or quarterly financial report but a specialized report focused on fundraising and the use of those funds. This matches the description of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length and detail confirm it is the report itself, not just an announcement of a report. Therefore, the correct classification is CAP.
2025-08-21 Chinese
关于2025年度“提质增效重回报”行动方案的半年度评估报告
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "半年 度评估报告" which translates to a "half-year assessment report" for the 2025 action plan of the company. It provides detailed operational, financial, and strategic progress for the first half of 2025, including financial figures, R&D updates, market performance, governance improvements, and investor relations activities. The content is comprehensive and covers substantive financial and business data for a period shorter than a full fiscal year. It is not a brief announcement or a certification but a detailed report. Therefore, it fits the definition of an Interim / Quarterly Report (IR). The document length is 4380 characters, which is slightly below 5000, but the content is substantive and detailed, not a mere announcement or publication notice. Hence, the classification is IR with high confidence. H1 2025
2025-08-21 Chinese
2025年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2025 半年度报告摘要' which translates to '2025 Half-Year Report Summary'. It contains detailed financial data for the half-year period, including total assets, net profit, revenue, earnings per share, and shareholder information. The document explicitly states it is a summary of the half-year report and references the full report for more details. The presence of comprehensive financial data and management discussion indicates this is a financial report for a period shorter than a full fiscal year. The document length is 3401 characters, which is relatively short but contains substantive financial data, not just an announcement or a link to a report. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-08-21 Chinese
关于与关联方共同投资暨关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shenzhen Huitai Medical Devices Co., Ltd. regarding a related-party transaction involving joint investment with related parties into another company, Shanghai Liliang Medical Technology Co., Ltd. It details the investment amounts, shareholding percentages, related parties involved, and the approval process by the board and independent directors. The document does not contain financial statements or detailed financial performance data but is a disclosure of a corporate transaction involving related parties. It is not an annual report, earnings release, or management report. It is a regulatory announcement about a related-party transaction and investment activity. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2025-08-21 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.